Title : Combination therapy with anti-ErbB3 monoclonal antibodies and EGFR TKIs potently inhibits non-small cell lung cancer.

Pub. Date : 2013 Aug

PMID : 23896512






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Anti-ErbB3 mAbs strongly synergize also with the dual EGFR and HER2 inhibitor lapatinib. Lapatinib erb-b2 receptor tyrosine kinase 3 Homo sapiens